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Transthyretin V122I in African Americans with
congestive heart failure (correspondence),
1724
Afro-Caribbeans
Role of inheritance and environment in
predisposition to vascular disease in people of
African descent, 1126
Afterdepolarizations
Sodium-calcium exchange initiated by the Ca2
transient, 1196
Age
Heart disease risk determines menopausal age
rather than the reverse, 1976
Influence of age, gender, and training on exercise
efficiency, 1049
Metabolic syndrome and age-related progression of
aortic stiffness, 72
Payments for debts associated with exercise can
become higher as we age and limit exercise
capacity (editorial), 1058
Aggregometry
Platelet aspirin resistance detection validation
(letter), 2565
Aging
See also Elderly; Older adults
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Relationship between atheroma regression and
change in lumen size after infusion of
apolipoprotein A-I Milano, 992
Apolipoprotein B-100
Oxidized phospholipids predict the presence and
progression of carotid and femoral
atherosclerosis and symptomatic cardiovascular
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Delayed gadolinium-enhanced cardiac magnetic
resonance in patients with chronic myocarditis
presenting with heart failure or recurrent
arrhythmias, 1649
Genomics and cardiac arrhythmias, 9
Microvolt T-wave alternans and the risk of death
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(12 months) serial intravascular ultrasound,
1363
Serum plant sterols and atherosclerosis: is there a
place for statin-ezetimibe combination?
(letter), 1496
Atherosclerotic plaque
Accuracy of 64-slice computed tomography to
classify and quantify plaque volumes in the
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plaques: a link between inflammation and
cerebrovascular events, 2201
Radionuclide imaging for the detection of
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atrial fibrillation, 1401
Genomics and cardiac arrhythmias, 9
Highest dominant frequencies in atrial fibrillation
(editorial), 1408
Improved atrial mechanical efficiency during
alternate- and multiple-site atrial pacing
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persistent and permanent atrial fibrillation,
2504
Phrenic nerve injury after atrial fibrillation catheter
ablation, 2498
Prevention of atrial fibrillation by angiotensin-
converting enzyme inhibitors and angiotensin
II receptor blockers (letter), 889
Relationship between stature and the prevalence of
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B-type natriuretic peptides and the stressed heart
(editorial), 749
Coming of age of natriuretic peptides (editorial), 61
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(correspondence), 464
Calcium transient
Sodium-calcium exchange initiated by the Ca2
transient, 1196
Caloric restriction
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poisoning (letter), 690
Cardiac allograft vasculopathy
Coronary endothelial vasomotor function and
vascular remodeling in heart transplant
recipients randomized for tacrolimus or
cyclosporine immunosuppression, 1622
Cardiac arrest
Rapid induction of cerebral hypothermia is
enhanced with active compression-
decompression plus inspiratory impedance
threshold device cardiopulmonary resuscitation
in a porcine model of cardiac arrest, 835
ST-segment elevation myocardial infarction:
recommendations on triage of patients to
heart attack centers, 1339
Cardiac function
Cardiac function and heart failure, D18
Cardiac regeneration
Cardiac regeneration, 1769
Cardiac rest
Cardiac rest and reserve function in patients with
Fontan circulation, 2528
Cardiac resynchronization therapy
Biomarker of myocardial fibrosis predicts long-term
response to cardiac resynchronization therapy,
2335
Year in clinical electrophysiology, 1207
Cardiac surgery
Randomised controlled trial of the effects of remote
ischemic preconditioning on children
undergoing cardiac surgery; first clinical
application in humans, 2277
Total of 1,007 percutaneous coronary interventions
without onsite cardiac surgery, 1713
Valvular heart disease/cardiac surgery, D37
Year in cardiovascular surgery, 2094
Cardiac transplantation
Effects of gender on peak oxygen consumption and
the timing of cardiac transplantation, 2237
Timing for transplant; superior genetics or social
prejudice (editorial), 2243
Cardiologists
Morphed specialist—an androsphinx? (letter), 1088
Cardiology
Cardiology in a flat world, 882
Cardiomyocytes
Microvascular permeabilization and cardiomyocyte
injury provoked by myocardial contrast
echocardiography in a canine model, 1464
Serofendic acid, a novel substance extracted from
fetal calf serum, protects against oxidative
stress in neonatal rat cardiac myocytes, 1882
Cardiomyopathy
See also Hypertrophic cardiomyopathy; Ischemic
cardiomyopathy
Fabry’s disease cardiomyopathy, 1663
Cardiopulmonary resuscitation
Levosimendan improves cardiopulmonary
resuscitation and survival by KATP channel
activation (correspondence), 1083
Rapid induction of cerebral hypothermia is
enhanced with active compression-
decompression plus inspiratory impedance
threshold device cardiopulmonary resuscitation
in a porcine model of cardiac arrest, 835
Cardiovascular disease
Coronary calcification, coronary disease risk factors,
C-reactive protein, and atherosclerotic
cardiovascular disease events: The St. Francis
Heart Study (letter), 2339
Hormone replacement therapy and the
cardiovascular system, 1741
Metabolic syndrome and the risk of cardiovascular
disease in older adults, 1595
Nitric oxide metabolites and cardiovascular disease
(editorial), 580
Oxidized phospholipids predict the presence and
progression of carotid and femoral
atherosclerosis and symptomatic cardiovascular
disease: five-year prospective results from the
Bruneck study, 2219
Prevalence of the metabolic syndrome and its
relation to cardiovascular disease in an elderly
Chinese population, 1588
Targeting cholesteryl ester transfer protein for the
prevention and management of cardiovascular
disease, 492
Underestimated impact of smoking and smoking
cessation on the risk of secondary
cardiovascular disease events in patients with
stable coronary heart disease: prospective
cohort study (correspondence), 887
Cardiovascular magnetic resonance
Improved detection of coronary artery disease by
stress perfusion cardiovascular magnetic
resonance with the use of delayed
enhancement infarction imaging, 1630
Cardiovascular medicine
ACCF 2006 update for training in adult
cardiovascular medicine, 893
Carotid angiography
Learning curves and reliability measures for virtual
reality simulation in the performance
assessment of carotid angiography, 1796
Carotid artery disease
Year in interventional cardiology, 1689
Carotid artery plaque
Vascular smooth muscle cells apoptosis in
asymptomatic diabetic carotid plaques: role of
glycemic control (correspondence), 2118
Carotid artery stenosis
Myeloperoxidase predicts progression of carotid
stenosis in states of low HDL-cholesterol,
2212
Protected carotid stenting in high-risk patients with
severe carotid artery stenosis, 2384
Carotid artery stenting
Mechanisms and predictors of carotid artery stent
restenosis: a serial intravascular ultrasound
study, 2390
New insights into improving acute and long term
outcomes of carotid stenting (editorial), 2397
Protected carotid stenting in high-risk patients with
severe carotid artery stenosis, 2384
Rate, predictors, and consequences of hemodynamic
depression after carotid artery stenting, 1538
Carotid atherosclerosis
Oxidized LDL autoantibodies, chronic infections
and carotid atherosclerosis in a population-
based study, 2436
Oxidized phospholipids predict the presence and
progression of carotid and femoral
atherosclerosis and symptomatic cardiovascular
disease: five-year prospective results from the
Bruneck study, 2219
Pregnancy associated plasma protein-A is markedly
expressed by monocyte-macrophage cells in
vulnerable and ruptured carotid atherosclerotic
plaques: a link between inflammation and
cerebrovascular events, 2201
Carotid intima media thickness
Role of inheritance and environment in
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predisposition to vascular disease in people of
African descent, 1126
Carvedilol
Comparison of the effects of carvedilol and
metoprolol on well-being, morbidity, and
mortality (the “patient journey”) in patients
with heart failure, 1603
Effects of combined versus selective adrenergic
blockade on left ventricular and systemic
hemodynamics, myocardial substrate
preference, and regional perfusion in
conscious dogs with dilated cardiomyopathy,
1871
Catheter ablation
Phrenic nerve injury after atrial fibrillation catheter
ablation, 2498
Catheterization
Trans-septal catheterization in the electrophysiology
laboratory, 1037
CD40 ligand
Thromboxane-dependent CD40 ligand release in
type 2 diabetes mellitus, 391
Cell transplantation
Autologous myoblast transplantation for chronic
ischemic mitral regurgitation, 2086
Cerebral hypothermia
Rapid induction of cerebral hypothermia is
enhanced with active compression-
decompression plus inspiratory impedance
threshold device cardiopulmonary resuscitation
in a porcine model of cardiac arrest, 835
Cheatham-platinum stents
Covered Cheatham-platinum stents for aortic
coarctation, 1457
Chest pain
Prognosis of negative adenosine stress magnetic
resonance in patients presenting to an
emergency department with chest pain, 1427
Children
See also Pediatrics
Clinical outcome of 193 extracardiac Fontan
patients: the first 15 years, 2065
Evaluation of left ventricular systolic function in
pediatric sickle cell anemia patients using the
end systolic wall stress-VCFc relationship,
2283
Independent factors associated with mortality,
reintervention, and achievement of complete
repair in children with pulmonary atresia with
ventricular septal defect, 1448
Long-term bosentan treatment in children with
pulmonary arterial hypertension (letter), 1914
Oxidized low-density lipoprotein in children with
familial hypercholesterolemia and unaffected
siblings, 1803
Variations in adult congenital heart disease training
in adult and pediatric cardiology fellowship
programs (letter), 2128
Chinese population
Prevalence of the metabolic syndrome and its
relation to cardiovascular disease in an elderly
Chinese population, 1588
Chlamydia pneumoniae
Correlation between Chlamydia pneumoniae
detection from coronary angioplasty balloons
and atherosclerosis severity (correspondence),
1229
Cholesteryl ester transfer protein
Targeting cholesteryl ester transfer protein for the
prevention and management of cardiovascular
disease, 492
Chronic mesenteric ischemia
Endovascular therapy for chronic mesenteric
ischemia, 944
Chronic myocarditis
Delayed gadolinium-enhanced cardiac magnetic
resonance in patients with chronic myocarditis
presenting with heart failure or recurrent
arrhythmias, 1649
Chronic obstructive pulmonary disease
Reduction of morbidity and mortality by statins,
angiotensin-converting enzyme inhibitors, and
angiotensin receptor blockers in patients with
chronic obstructive pulmonary disease, (June
20: Mancini)
Chronic renal failure
Cardiovascular morbidity and mortality in the
Atherosclerosis and Folic Acid
Supplementation Trial (ASFAST) in chronic
renal failure, 1108
Chronotropic response
Effects of normal aging on left ventricular
lusitropic, inotropic, and chronotropic
responses to dobutamine, 1440
Cineventriculography
Analysis of regional left ventricular function by
cineventriculography, cardiac magnetic
resonance imaging, and unenhanced and
contrast-enhanced echocardiography, 121
Circadian rhythm
Link between arterial inflammation and circadian
rhythm: the oversight aspect in the year 2004
(letter), 688
Clinical trials
Cardiovascular risk in patients with human
immunodeficiency virus infection (editorial),
1124
Multi-Ethnic Study of Atherosclerosis (MESA)
and myocardial function (editorial), 1159
Noninvasive detection of subclinical coronary
atherosclerosis coupled with assessment of
changes in plaque characteristics using novel
invasive imaging modalities, 1134
Outline for public registration of clinical trials
evaluating medical devices, 1518
Clopidogrel
Aspirin and clopidogrel drug response in patients
undergoing percutaneous coronary
intervention, 27
Effect of platelet antigen polymorphism on platelet
inhibition by aspirin, clopidogrel, or their
combination, 541
Impact of adenosine diphosphate and calcium
chelation on platelet aggregation testing in
patients receiving clopidogrel therapy
(correspondence), 464
Optimal timing for the initiation of pre-treatment
with 300 mg clopidogrel before percutaneous
coronary intervention, 939
Coagulopathy
Risk of hemorrhage among patients with warfarin-
associated coagulopathy, 804
Coarctation of the aorta
Covered Cheatham-platinum stents for aortic
coarctation, 1457
Results of catheter-based therapy compared with
surgical repair of adult aortic coarctation,
1101
Cocaine
Evidence of cocaine-related coronary atherosclerosis
in young patients with myocardial infarction,
2120
Complement factor H
Common polymorphism in the complement factor
H gene is associated with increased risk of
myocardial infarction, 1568
Complementary medicine
Complementary medicine has no place in
cardiovascular medicine (letter), 1498
Computed tomography
See also Multi-detector computed tomography;
Multi-slice computed tomography; Single-
photon emission computed tomography
Accuracy of 64-slice computed tomography to
classify and quantify plaque volumes in the
proximal coronary system, 672
Highlights of the year in JACC 2005, 184
Multislice computed tomography for detection of
patients with aortic valve stenosis and
quantification of severity, 1410
Promise of quantitative computed tomography
coronary angiography and noninvasive
segmental coronary plaque quantification
(editorial), 678
Quantification of coronary lesions by 64-slice
computed tomography compared with
quantitative coronary angiography and
intravascular ultrasound (letter), 891
Radiation exposure of computed tomography and
direct intracoronary angiography, 1846
Task force 12: training in advanced cardiovascular
imaging (computed tomography), 915
Computed tomography angiography
Atherosclerotic plaque characterization by
multidetector row computed tomography
angiography, C40
Comparison of radiation doses from multislice
computed tomography coronary angiography
and conventional diagnostic angiography,
1840
Promise of quantitative computed tomography
coronary angiography and noninvasive
segmental coronary plaque quantification
(editorial), 678
64-slice peripheral computed tomography
angiography: a clinical accuracy evaluation
(correspondence), 1495
Congenital heart disease
Covered Cheatham-platinum stents for aortic
coarctation, 1457
Highlights of the year in JACC 2005, 184
Independent factors associated with mortality,
reintervention, and achievement of complete
repair in children with pulmonary atresia with
ventricular septal defect, 1448
Influence of percutaneous closure of patent ductus
arteriosus on left ventricular size and function,
1060
Maternal homocysteine and congenital heart defects
(correspondence), 683
Pediatric cardiology and adult congenital heart
disease, D33
Report of the National Heart, Lung, and Blood
Institute working group on research in adult
congenital heart disease, 701
Results of catheter-based therapy compared with
surgical repair of adult aortic coarctation,
1101
Transcatheter closure of perimembranous
ventricular septal defects using the new
Amplatzer Membranous VSD Occluder, 319
Validation and re-evaluation of a discriminant
model predicting anatomic suitability for
biventricular repair in neonates with aortic
stenosis, 1858
Variations in adult congenital heart disease training
in adult and pediatric cardiology fellowship
programs (letter), 2128
Constrictive pericarditis
Brain natriuretic peptide levels in constrictive
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pericarditis and restrictive cardiomyopathy
(correspondence), 1489
Continuous positive airway pressure
Obstructive sleep apnea syndrome, 1433
Contractile dysfunction
Involvement of the nicotinamide adenosine
dinucleotide phosphate oxidase isoform Nox2
in cardiac contractile dysfunction occurring in
response to pressure overload, 817
Contrast agents
See also Gadolinium
Novel contrast removal system from the coronary
sinus using an adsorbing column during
coronary angiography in a porcine model,
1866
Removal of iodine contrast from coronary sinus in
swine during coronary angiography
(correspondence), 465
When two tests are better than one (editorial),
1639
Contrast echocardiography
Highlights of the year in JACC 2005, 184
Microvascular permeabilization and cardiomyocyte
injury provoked by myocardial contrast
echocardiography in a canine model, 1464
Potential bioeffects of ultrasonic destruction of
microbubble contrast agents (editorial), 1469
Year in echocardiography, 856
Coronary angiography
Novel contrast removal system from the coronary
sinus using an adsorbing column during
coronary angiography in a porcine model,
1866
Promise of quantitative computed tomography
coronary angiography and noninvasive
segmental coronary plaque quantification
(editorial), 678
Removal of iodine contrast from coronary sinus in
swine during coronary angiography
(correspondence), 465
Coronary arteries
Coronary arteries after arterial switch surgery
(letter), 1734
Initial experience with a magnetic navigation
system for percutaneous coronary intervention
in complex coronary artery lesions, 515
Number of yellow plaques detected in a coronary
artery is associated with future risk of acute
coronary syndrome detection of vulnerable
patients by angioscopy, 2194
Plaque composition and its relationship with
acknowledged shear stress patterns in coronary
arteries (correspondence), 884
Sildenafil improves coronary artery patency in a
canine model of platelet-mediated cyclic
coronary occlusion after thrombolysis, 1471
Coronary artery bypass grafting
Comparison of coronary artery bypass surgery with
percutaneous coronary intervention with drug-
eluting stents for unprotected left main
coronary artery disease, 864
Effects of N-3 fatty acids on postoperative atrial
fibrillation following coronary artery bypass
grafting (letter), 467
Evaluating the risk of coronary surgery and
percutaneous coronary intervention (editorial),
669
Intense vasoconstriction in response to aspirate
from stented saphenous vein aortocoronary
bypass grafts, 981
Coronary artery calcification
Coronary calcification, coronary disease risk factors,
C-reactive protein, and atherosclerotic
cardiovascular disease events: The St. Francis
Heart Study (letter), 2339
Relationship between plasma osteoprotegerin levels
and coronary artery calcification in
uncomplicated type 2 diabetic subjects, 1850
Coronary artery disease
Accuracy of multislice computed tomography in the
preoperative assessment of coronary disease in
patients with aortic valve stenosis, 2020
Angiotensin-converting enzyme inhibitors in
coronary artery disease and preserved left
ventricular systolic function, 1576
Are drug-eluting stents the preferred treatment for
multivessel coronary artery disease?, 22
Cardiac rehabilitation, exercise training, and
psychosocial risk factors (letter), 212
Comparison of B-type natriuretic peptides for
assessment of cardiac function and prognosis
in stable ischemic heart disease, 52
Comparison of coronary artery bypass surgery with
percutaneous coronary intervention with drug-
eluting stents for unprotected left main
coronary artery disease, 864
Coronary calcification, coronary disease risk factors,
C-reactive protein, and atherosclerotic
cardiovascular disease events: The St. Francis
Heart Study (letter), 2339
Coronary MDCT—a new standard for preoperative
risk assessment?, 2025
Correlation between Chlamydia pneumoniae
detection from coronary angioplasty balloons
and atherosclerosis severity (correspondence),
1229
Detection of coronary artery disease in
asymptomatic patients with type 2 diabetes
mellitus, 65
Distal left main coronary disease is a major
predictor of outcome in patients undergoing
percutaneous intervention in the drug-eluting
stent era, 1530
Hypertension, menopause, and coronary artery
disease risk in the Women’s Ischemia
Syndrome Evaluation (WISE) study, 50S
Impact of body mass index on cardiac mortality in
patients with known or suspected coronary
artery disease undergoing myocardial perfusion
single-photon emission computed
tomography, 1418
Improved detection of coronary artery disease by
stress perfusion cardiovascular magnetic
resonance with the use of delayed
enhancement infarction imaging, 1630
Mental stress provokes ischemia in coronary artery
disease subjects without exercise- or
adenosine-induced ischemia, 987
Myocardial contrast echocardiography for the
detection of coronary artery stenosis, 141
Predictors of adverse outcome among patients with
hypertension and coronary artery disease, 547
Prognostic value of pharmacological stress
echocardiography in diabetic and nondiabetic
patients with known or suspected coronary
artery disease, 605
Prospective aortic screening in men with coronary
aneurysms (correspondence), 1227
Protective anti-inflammatory phenotype in high-risk
individuals who do not develop coronary
artery disease (correspondence), 1085
Serum adiponectin levels are an independent
predictor of the extent of coronary artery
disease in men, 2124
Sirolimus-eluting versus paclitaxel-eluting stent
implantation for the percutaneous treatment
of left main coronary artery disease, 507
Coronary artery spasm
Life-threatening coronary artery spasm following
sirolimus-eluting stent deployment (letter),
1911
Coronary calcium
Highlights of the year in JACC 2005, 184
Coronary circulation
Relationship between increasing body weight,
insulin resistance, inflammation, adipocytokine
leptin, and coronary circulation function, 1188
Coronary heart disease
Coronary risk factors and myocardial perfusion in
asymptomatic adults, 565
Underestimated impact of smoking and smoking
cessation on the risk of secondary
cardiovascular disease events in patients with
stable coronary heart disease: prospective
cohort study (correspondence), 887
Coronary lesions
Bifurcation coronary lesions and the “crush”
technique (letter), 2566
Quantification of coronary lesions by 64-slice
computed tomography compared with
quantitative coronary angiography and
intravascular ultrasound (letter), 891
Coronary obstructions
Racial differences in prevalence of coronary
obstructions among men with positive nuclear
imaging studies, 2034
Coronary occlusions
Prediction of left ventricular function after drug-
eluting stent implantation for chronic total
coronary occlusions, 721
Coronary plaque
Accuracy of 64-slice computed tomography to
classify and quantify plaque volumes in the
proximal coronary system, 672
Accuracy of in vivo coronary plaque morphology
assessment: a validation study of in vivo
virtual histology compared with in vitro
histopathology, 2405
Assessment of vulnerable plaques causing acute
coronary syndrome using integrated
backscatter intravascular ultrasound, 734
Atherosclerotic plaque characterization by
multidetector row computed tomography
angiography, C40
Cellular immunostaining of angiotensin-converting
enzyme in human coronary atherosclerotic
plaques, 1143
C-reactive protein and the vascular endothelium
(editorial), 1379
Elevated plaque temperature in non-culprit de novo
atheromatous lesions of patients with acute
coronary syndromes, 301
Imaging vulnerable plaque by ultrasound, C32
Intracoronary palpography for vulnerable plaque
assessment, C86
Intracoronary thermography for detection for high-
risk vulnerable plaques, C80
Near-infrared spectroscopy for the detection of
vulnerable coronary artery plaques, C92
New opportunities for identification and reduction
of coronary risk, C2
Noncalcified and calcified coronary plaque detection
by contrast-enhanced multi-detector
computed tomography: a study of
interobserver agreement (correspondence), 207
Noninvasive assessment of plaque morphology and
composition in culprit and stable lesions in
acute coronary syndrome and stable lesions in
stable angina by multidetector computed
tomography, 1655
Noninvasive detection of subclinical coronary
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atherosclerosis coupled with assessment of
changes in plaque characteristics using novel
invasive imaging modalities, 1134
Number of yellow plaques detected in a coronary
artery is associated with future risk of acute
coronary syndrome detection of vulnerable
patients by angioscopy, 2194
Pathology of the vulnerable plaque, C13
Plaque characterization with optical coherence
tomography, C69
Promise of quantitative computed tomography
coronary angiography and noninvasive
segmental coronary plaque quantification
(editorial), 678
Radionuclide imaging for the detection of
inflammation in vulnerable plaques, C57
Role of magnetic resonance and intravascular
magnetic resonance in the detection of
vulnerable plaques, C48
Coronary sinus
Novel contrast removal system from the coronary
sinus using an adsorbing column during
coronary angiography in a porcine model,
1866
Removal of iodine contrast from coronary sinus in
swine during coronary angiography
(correspondence), 465
Shortening of fibrillatory cycle length in the
pulmonary vein during vagal excitation, 774
Coronary vascular reactivity
Impaired coronary vascular reactivity and functional
capacity in women, 44S
C-reactive protein
Anti-inflammatory action of angiotensin-converting
enzyme inhibitors and angiotensin receptor
blockers (letter), 889
Coronary calcification, coronary disease risk factors,
C-reactive protein, and atherosclerotic
cardiovascular disease events: The St. Francis
Heart Study (letter), 2339
C-reactive protein and other emerging blood
biomarkers to optimize risk stratification of
vulnerable patients, C19
C-reactive protein and the vascular endothelium
(editorial), 1379
C-reactive protein induces matrix
metalloproteinase-1 and -10 in human
endothelial cells, 1369
Decline in C-reactive protein after successful
ablation of long-lasting persistent atrial
fibrillation (correspondence), 1231
Early inflammation and risk of long-term
development of heart failure and mortality in
survivors of acute myocardial infarction, 962
Relationship between plasma osteoprotegerin levels
and coronary artery calcification in
uncomplicated type 2 diabetic subjects, 1850
Release of C-reactive protein by stenting (letter),
1733
Creatine kinase
Prognostic implications of creatine kinase elevation
after primary percutaneous coronary
intervention for acute myocardial infarction,
951
Creatine kinase-MB
Frequency and clinical implications of discordant
creatine kinase-MB and troponin
measurement in acute coronary syndromes,
312
“Crush” technique
Bifurcation coronary lesions and the “crush”
technique (letter), 2566
Limitations of Crush technique (letter), 1915
Long-term outcomes following stenting of
bifurcation lesions utilizing the “crush”
technique: predictors of an adverse outcome,
1949
Cyclic Arg-Gly-Asp peptide
Novel drug-eluting stent coated with an integrin-
binding cyclic Arg-Gly-Asp peptide inhibits
neointimal hyperplasia by recruiting
endothelial progenitor cells, 1786
Cyclosporin A
Coronary endothelial vasomotor function and
vascular remodeling in heart transplant
recipients randomized for tacrolimus or
cyclosporine immunosuppression, 1622
Decompensated heart failure
Clinical presentation, management, and in-hospital
outcome of patients admitted with acute
decompensated heart failure with preserved
systolic function, 76
Non-hypotensive low dose nesiritide has differential
renal effects compared to standard dose
nesiritide in patients with acute
decompensated heart failure and renal
dysfunction (correspondence), 2334
Degenerative valve disease
Human degenerative valve disease is associated with
up-regulation of low-density lipoprotein
receptor-related protein 5 receptor-mediated
bone formation, 1707
Delayed enhancement-magnetic resonance imaging
Delayed gadolinium-enhanced cardiac magnetic
resonance in patients with chronic myocarditis
presenting with heart failure or recurrent
arrhythmias, 1649
Reproducibility of chronic and acute infarct size
measurement by delayed enhancement-
magnetic resonance imaging, 1641
Diabetes mellitus
Detection of coronary artery disease in
asymptomatic patients with type 2 diabetes
mellitus, 65
Diabetes lowers six-minute walk test performance
in heart failure (correspondence), 1909
Dobutamine stress echocardiography in patients
with diabetes mellitus, 1029
Family history of diabetes mellitus is a major
determinant of endothelial function, (June 20:
Goldfine, Beckman)
Highlights of the year in JACC 2005, 184
Increased myocardial fatty acid metabolism in
patients with type 1 diabetes mellitus, 598
Metabolic syndrome: connecting and reconciling
cardiovascular and diabetes worlds, 1093
Peripheral arterial disease in patients with diabetes,
921
Preventing type 2 diabetes mellitus with
angiotensin blockade: is it clinically relevant?
(letter), 1913
Prognostic value of pharmacological stress
echocardiography in diabetic and nondiabetic
patients with known or suspected coronary
artery disease, 605
Relationship between plasma osteoprotegerin levels
and coronary artery calcification in
uncomplicated type 2 diabetic subjects, 1850
Thromboxane-dependent CD40 ligand release in
type 2 diabetes mellitus, 391
Vascular smooth muscle cells apoptosis in
asymptomatic diabetic carotid plaques: role of
glycemic control (correspondence), 2118
Diabetic cardiomyopathy
Paradoxical increase in ventricular torsion and
systolic torsion rate in type I diabetic patients
under tight glycemic control, 384
Pathogenesis of myocardial fibrosis in the setting of
diabetic cardiomyopathy, 693
Diagnostic testing
Diagnostic testing, D23
Diastolic blood pressure
Hypertension and smoking are associated with
reduced regional left ventricular function in
asymptomatic individuals, 1150
Diastolic dysfunction
Diastolic heart failure can be diagnosed by
comprehensive two-dimensional and Doppler
echocardiography, 500
Diastolic function
Long-term caloric restriction ameliorates the
decline in diastolic function in humans, 398
Diastolic wall stress
B-type natriuretic peptide strongly reflects diastolic
wall stress in patients with chronic heart
failure, 742
Diet
High fat/high carbohydrate diet induces aortic valve
disease in C57BL/6J mice, 851
Long-term caloric restriction ameliorates the
decline in diastolic function in humans, 398
Dilated cardiomyopathy
Effects of combined versus selective adrenergic
blockade on left ventricular and systemic
hemodynamics, myocardial substrate
preference, and regional perfusion in
conscious dogs with dilated cardiomyopathy,
1871
Viruses and other environmental factors as possible
sources of phenotypic heterogeneity in familial
dilated cardiomyopathy (letter), 689
Dipyridamole stress N-13 ammonia positron
emission tomography
Treadmill exercise produces larger perfusion defects
than dipyridamole stress N-13 ammonia
positron emission tomography, 411
Dobutamine
Effects of normal aging on left ventricular
lusitropic, inotropic, and chronotropic
responses to dobutamine, 1440
Dobutamine stress echocardiography
Dobutamine stress echocardiography in patients
with diabetes mellitus, 1029
Year in echocardiography, 856
Dobutamine stress myocardial perfusion imaging
Risk stratification with electrocardiographic-gated
dobutamine stress technetium-99m sestamibi
single-photon emission tomographic imaging,
781
Doppler echocardiography
Diastolic heart failure can be diagnosed by
comprehensive two-dimensional and Doppler
echocardiography, 500
Flow-dependent changes in Doppler-derived aortic
valve effective orifice area are real and not due
to artifact, 131
Grading of myocardial dysfunction by tissue
Doppler echocardiography, 1672
Hemodynamic assessment of aortic stenosis
(editorial), 138
Year in echocardiography, 856
Drug-eluting stents
See also Stents
Allergic reactions after the implantation of drug-
eluting stents (editorial), 182
Are drug-eluting stents the preferred treatment for
multivessel coronary artery disease?, 22
Clinical results of a platelet glycoprotein IIb/IIIa
receptor blocker (abciximab: ReoPro)-coated
stent in acute myocardial infarction, 933
Comparison of coronary artery bypass surgery with
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percutaneous coronary intervention with drug-
eluting stents for unprotected left main
coronary artery disease, 864
Coronary stent thrombosis in the current drug-
eluting stent era: insights from the ERACI
III trial (correspondence), 205
Distal left main coronary disease is a major
predictor of outcome in patients undergoing
percutaneous intervention in the drug-eluting
stent era, 1530
Drug eluting stent restenosis: the pattern predicts
the outcome, 2399
Drug-eluting stent thrombosis: a pooled analysis
(letter), 214
Drug-eluting stenting for unprotected left main
coronary artery disease (editorial), 878
Drug-eluting stents and late adverse clinical
outcomes: lessons learned, lessons awaited,
2112
Drug-eluting stents are safe and effective (editorial),
1361
Drug-eluting stents in the treatment of
intermediate lesions: pooled analysis from four
randomized trials, 2164
Endothelial dysfunction after drug-eluting stent was
never predicted in clinical studies (letter),
1911
Highlights of the year in JACC 2005, 184
Hypersensitivity cases associated with drug-eluting
coronary stents, 175
Intravascular ultrasound analysis of polymer-based
paclitaxel-eluting stents (letter), 470
Limitations of Crush technique (letter), 1915
Novel drug-eluting stent coated with an integrin-
binding cyclic Arg-Gly-Asp peptide inhibits
neointimal hyperplasia by recruiting
endothelial progenitor cells, 1786
Persistence of neointimal growth 12 months after
intervention and occurrence of delayed
restenosis in patients with left main coronary
artery disease treated with drug-eluting stents
(correspondence), 1491
Prediction of left ventricular function after drug-
eluting stent implantation for chronic total
coronary occlusions, 721
Sirolimus and paclitaxel on polymer-based drug-
eluting stents, 708
Value of selectivity (editorial), 719
Duke Activity Status Index
Impaired coronary vascular reactivity and functional
capacity in women, 44S
Value of estimated functional capacity in estimating
outcome, 36S
Dyssynergy
Patients with hibernating myocardium show altered
left ventricular volumes and shape, which
revert after revascularization, 969
Early afterdepolarizations
Sodium-calcium exchange initiated by the Ca2
transient, 1196
Echocardiography
Analysis of regional left ventricular function by
cineventriculography, cardiac magnetic
resonance imaging, and unenhanced and
contrast-enhanced echocardiography, 121
Do you see what I see? (editorial), 129
Dynamic ventricular dyssynchrony: an exercise-
echocardiography study, 2253
Fabry’s disease cardiomyopathy, 1663
Grading of myocardial dysfunction by tissue
Doppler echocardiography, 1672
Highlights of the year in JACC 2005, 184
Imaging and quantification of myocardial perfusion
using real-time three-dimensional
echocardiography, 146
Measurement of strain and strain rate by
echocardiography, 1313
Microvascular permeabilization and cardiomyocyte
injury provoked by myocardial contrast
echocardiography in a canine model, 1464
Myocardial contrast echocardiography for the
detection of coronary artery stenosis, 141
Noninvasive myocardial strain measurement by
speckle tracking echocardiography, 789
Potential bioeffects of ultrasonic destruction of
microbubble contrast agents (editorial), 1469
Prediction of cardiovascular outcomes with left
atrial size, 1018
Predictive value of normal left atrial volume in
stress echocardiography, 1024
Prognostic value of pharmacological stress
echocardiography in diabetic and nondiabetic
patients with known or suspected coronary
artery disease, 605
Year in echocardiography, 856
Editorials
Allergic reactions after the implantation of drug-
eluting stents, 182
B-type natriuretic peptides and the stressed heart,
749
Cardiovascular aging, 403
Cardiovascular risk in patients with human
immunodeficiency virus infection, 1124
Clinical research designs and implantable
defibrillator indications, 108
Coming of age of natriuretic peptides, 61
C-reactive protein and the vascular endothelium,
1379
Diversity in JACC, 2561
Do you see what I see?, 129
Drug-eluting stenting for unprotected left main
coronary artery disease, 878
Drug-eluting stents are safe and effective, 1361
Emerging role of statins in the treatment of heart
failure, 342
Evaluating the risk of coronary surgery and
percutaneous coronary intervention, 669
Future of an illusion, 2380
Growing problem of obesity and the heart, 617
Hemodynamic assessment of aortic stenosis, 138
Hibernating myocardium, 978
Highest dominant frequencies in atrial fibrillation,
1408
Incomplete neointimal coverage of sirolimus-eluting
stents (editorial), 2108
Limitations of left ventricular ejection fraction as
the major determinant for primary prevention
implantable cardioverter-defibrillators, 1167
Mapping the journey, 1612
Multi-Ethnic Study of Atherosclerosis (MESA)
and myocardial function, 1159
New insights into improving acute and long term
outcomes of carotid stenting, 2397
Nitric oxide metabolites and cardiovascular disease,
580
Patent foramen ovale, guilty but only as a gang
member and for a lesser crime, 446
Payments for debts associated with exercise can
become higher as we age and limit exercise
capacity, 1058
Perils of connectivity, 2116
Positively magnetic north, 1646
Potential bioeffects of ultrasonic destruction of
microbubble contrast agents, 1469
Promise of quantitative computed tomography
coronary angiography and noninvasive
segmental coronary plaque quantification, 678
QTc prolongation and sudden cardiac death, 368
Regional left ventricular electric and mechanical
activation and relaxation, 173
Timing for transplant; superior genetics or social
prejudice, 2243
Tincture of time, 1818
Unsung hero, 1722
Upstream/downstream, 538
Value of selectivity, 719
When two tests are better than one, 1639
Effective orifice area
Flow-dependent changes in Doppler-derived aortic
valve effective orifice area are real and not due
to artifact, 131
Hemodynamic phenomenon or geometric
discrepancy? (letter), 213
Elderly
See also Aging; Older adults
Metabolic syndrome and the risk of cardiovascular
disease in older adults, 1595
Prevalence of the metabolic syndrome and its
relation to cardiovascular disease in an elderly
Chinese population, 1588
Electrocardiogram
Pre-hospital electrocardiogram and time to
reperfusion in patients with acute myocardial
infarction, 2000–2002, 1544
Electrocardiography
Pre-hospital 12-lead electrocardiography programs,
485
Prolonged QTc interval and risk of sudden cardiac
death in a population of older adults, 362
Ratio of late to early T-wave peak amplitude in
24-h electrocardiographic recordings as
indicator of symptom history in patients with
long-QT syndrome types 1 and 2, 112
Risk stratification with electrocardiographic-gated
dobutamine stress technetium-99m sestamibi
single-photon emission tomographic imaging,
781
Electrophysiology
Highlights of the year in JACC 2005, 184
Sodium-calcium exchange initiated by the Ca2
transient, 1196
Task force 6: training in specialized
electrophysiology, cardiac pacing, and
arrhythmia management, 904
Trans-septal catheterization in the electrophysiology
laboratory, 1037
Year in clinical electrophysiology, 1207
Embolism
Patent foramen ovale, guilty but only as a gang
member and for a lesser crime (editorial), 446
Patent foramen ovale: innocent or guilty?, 440
Year in interventional cardiology, 1689
Enalapril
Early versus delayed enalapril in patients with left
ventricular systolic dysfunction: impact on
morbidity and mortality 15 years after the
SOLVD trial (correspondence), 1904
Endocardial mapping
Sites of focal atrial activity characterized by
endocardial mapping during atrial fibrillation,
2005
Endochondral bone
Human degenerative valve disease is associated with
up-regulation of low-density lipoprotein
receptor-related protein 5 receptor-mediated
bone formation, 1707
Endomyocardial biopsy
Delayed gadolinium-enhanced cardiac magnetic
resonance in patients with chronic myocarditis
presenting with heart failure or recurrent
arrhythmias, 1649
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Endothelial cells
C-reactive protein induces matrix
metalloproteinase-1 and -10 in human
endothelial cells, 1369
Drug-eluting stents and late adverse clinical
outcomes: lessons learned, lessons awaited,
2112
Endothelial dysfunction
Endothelial dysfunction after drug-eluting stent was
never predicted in clinical studies (letter),
1911
Family history of diabetes mellitus is a major
determinant of endothelial function, 2456
Plasma nitroso compounds are decreased in patients
with endothelial dysfunction, 573
Endothelial progenitor cells
Novel drug-eluting stent coated with an integrin-
binding cyclic Arg-Gly-Asp peptide inhibits
neointimal hyperplasia by recruiting
endothelial progenitor cells, 1786
Endothelin-1
Coronary endothelial vasomotor function and
vascular remodeling in heart transplant
recipients randomized for tacrolimus or
cyclosporine immunosuppression, 1622
Endothelium
C-reactive protein and the vascular endothelium
(editorial), 1379
Endovascular therapy
Endovascular therapy for chronic mesenteric
ischemia, 944
Environment
Role of inheritance and environment in
predisposition to vascular disease in people of
African descent, 1126
Eptifibatide
Clinical characteristics predict benefits from
eptifibatide therapy during coronary stenting,
715
Correlates of bleeding events among moderate to
high-risk patients undergoing percutaneous
coronary intervention and treated with
eptifibatide: observations from PROTECT–
TIMI-30, 2374
Randomized trial to evaluate the relative protection
against post-PCI microvascular dysfunction,
ischemia and inflammation among anti-
platelet and anti-thrombotic agents: the
PROTECT–TIMI-30 trial, 2364
Erythropoietin
Highlights of the year in JACC 2005, 184
Serum erythropoietin levels and infarct size (letter),
468
Ethnicity
Impact of hospital volume on racial disparities in
cardiovascular procedure mortality, 417
Exercise
Caffeine decreases exercise-induced myocardial flow
reserve, 405
Delayed calf muscle phosphocreatine recovery after
exercise identifies peripheral arterial disease,
2289
Diabetes lowers six-minute walk test performance
in heart failure (correspondence), 1909
Diastolic stress echocardiography: hemodynamic
validation and clinical significance of
estimation of ventricular filling pressure with
exercise, 1891
Dynamic ventricular dyssynchrony: an exercise-
echocardiography study, 2253
Impaired stroke volume response to exercise in
pulmonary arterial hypertension
(correspondence), 1732
Influence of age, gender, and training on exercise
efficiency, 1049
Mental stress provokes ischemia in coronary artery
disease subjects without exercise- or
adenosine-induced ischemia, 987
Payments for debts associated with exercise can
become higher as we age and limit exercise
capacity (editorial), 1058
Treadmill exercise produces larger perfusion defects
than dipyridamole stress N-13 ammonia
positron emission tomography, 411
Exercise training
Cardiac rehabilitation, exercise training, and
psychosocial risk factors (letter), 212
Extracardiac Fontan circulation
Clinical outcome of 193 extracardiac Fontan
patients: the first 15 years, 2065
Ezetimibe
Safety and efficacy of long-term co-administration
of fenofibrate and ezetimibe in patients with
mixed hyperlipidemia, 1584
Serum plant sterols and atherosclerosis: is there a
place for statin-ezetimibe combination?
(letter), 1496
Fabry’s disease
Fabry’s disease cardiomyopathy, 1663
Familial hypercholesterolemia
Oxidized low-density lipoprotein in children with
familial hypercholesterolemia and unaffected
siblings, 1803
Fats
High fat/high carbohydrate diet induces aortic valve
disease in C57BL/6J mice, 851
Fatty acids
Increased myocardial fatty acid metabolism in
patients with type 1 diabetes mellitus, 598
Fellowship
Variations in adult congenital heart disease training
in adult and pediatric cardiology fellowship
programs (letter), 2128
Femoral atherosclerosis
Oxidized phospholipids predict the presence and
progression of carotid and femoral
atherosclerosis and symptomatic cardiovascular
disease: five-year prospective results from the
Bruneck study, 2219
Fenofibrate
Safety and efficacy of long-term co-administration
of fenofibrate and ezetimibe in patients with
mixed hyperlipidemia, 1584
Folic acid
Cardiovascular morbidity and mortality in the
Atherosclerosis and Folic Acid
Supplementation Trial (ASFAST) in chronic
renal failure, 1108
Fontan circulation
Cardiac rest and reserve function in patients with
Fontan circulation, 2528
Clinical outcome of 193 extracardiac Fontan
patients: the first 15 years, 2065
Fractional flow reserve
Fractional flow reserve of infarct related arteries
identifies reversible defects on non-invasive
myocardial perfusion imaging early after
myocardial infarction, 2187
G1648A
Genetic polymorphisms of platelet glycoprotein Ia
and the risk for premature myocardial
infarction: effects of the release of sCD40L
during the acute phase of premature
myocardial infarction, 1959
Gadolinium
See also Contrast agents
Characterization of radiofrequency ablation lesions
with gadolinium-enhanced cardiovascular
magnetic resonance imaging, 370
Delayed gadolinium-enhanced cardiac magnetic
resonance in patients with chronic myocarditis
presenting with heart failure or recurrent
arrhythmias, 1649
When two tests are better than one (editorial),
1639
Gender
Effects of gender on peak oxygen consumption and
the timing of cardiac transplantation, 2237
Influence of age, gender, and training on exercise
efficiency, 1049
Insights from the NHLBI-sponsored Women’s
Ischemia Syndrome Evaluation (WISE) study,
4S, 21S
Ischemic heart disease in women, 1S
Women, ischemic heart disease, revascularization,
and the gender gap, 63S
Genetic polymorphisms
Genetic polymorphisms of platelet glycoprotein Ia
and the risk for premature myocardial
infarction: effects of the release of sCD40L
during the acute phase of premature
myocardial infarction, 1959
Genetic testing
Effect of clinical phenotype on yield of long QT
syndrome genetic testing, 764
Genomics
Cardiac regeneration, 1769
Genomics and cardiac arrhythmias, 9
Geographical differences
Geographical differences in the rates of
angiographic restenosis and ischemia-driven
target vessel revascularization after
percutaneous coronary interventions, 34
Glucose-insulin-potassium
Glucose-insulin-potassium infusion in patients with
acute myocardial infarction without signs of
heart failure: The Glucose-Insulin-Potassium
Study (GIPS)-II (correspondence), 1730
Glutathione
Relationship between plasma levels of oxidized and
reduced thiols and early atherosclerosis in
healthy adults, 1005
Glycemic control
Vascular smooth muscle cells apoptosis in
asymptomatic diabetic carotid plaques: role of
glycemic control (correspondence), 2118
Glycoprotein Ia
Genetic polymorphisms of platelet glycoprotein Ia
and the risk for premature myocardial
infarction: effects of the release of sCD40L
during the acute phase of premature
myocardial infarction, 1959
Glycoprotein IIb/IIIa
Dependence of platelet thrombus stability on
sustained glycoprotein IIb/IIIa activation
through adenosine 5’-diphosphate receptor
stimulation and cyclic calcium signaling, 155
Glycoprotein IIb/IIIa inhibitors
Clinical results of a platelet glycoprotein IIb/IIIa
receptor blocker (abciximab: ReoPro)-coated
stent in acute myocardial infarction, 933
Randomized trial to evaluate the relative protection
against post-PCI microvascular dysfunction,
ischemia and inflammation among anti-
platelet and anti-thrombotic agents: the
PROTECT–TIMI-30 trial, 2364
Role of risk stratification in the decision to provide
upstream versus selective glycoprotein IIb/IIIa
inhibitors for acute coronary syndromes, 529
Upstream/downstream (editorial), 538
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Glycosphingolipids
Fabry’s disease cardiomyopathy, 1663
Granulocyte colony-stimulating factor
Cardioprotective effects of granulocyte colony-
stimulating factor in swine with chronic
myocardial ischemia, 842
Macrophage colony-stimulating factor treatment
after myocardial infarction attenuates left
ventricular dysfunction by accelerating infarct
repair, 626
Head-up tilt test
Implantable loop recorder study of highly
symptomatic vasovagal patients, 587
Health care
Big chill: adverse effects of public reporting on
access to health care (letter), 1737
Health status
Health status identifies heart failure outpatients at
risk for hospitalization or death, 752
Heart attack
See Cardiac arrest
Heart disease
Heart disease risk determines menopausal age
rather than the reverse, 1976
Insights from the NHLBI-sponsored Women’s
Ischemia Syndrome Evaluation (WISE) study,
4S
Ischemic heart disease in women, 1S
Menopause and cardiovascular risk: cause or
consequence?, 1984
Women and cardiovascular heart disease: clinical
implications from the Women’s Ischemia
Syndrome Evaluation (WISE) study, 59S
Heart failure
Aerobic training decreases B-type natriuretic
peptide expression and adrenergic activation
in patients with heart failure, 1835
Aquaretic effect of lixivaptan, an oral, non-peptide,
selective V2 receptor vasopressin antagonist,
in New York Heart Association functional
class II and III chronic heart failure patients,
1615
Atorvastatin improves left ventricular systolic
function and serum markers of inflammation
in nonischemic heart failure, 332
Atrial fibrillation and risk of clinical events in
chronic heart failure with and without left
ventricular systolic dysfunction: results from
the Candesartan in Heart Failure—
Assessment of Reduction in Mortality and
Morbidity (CHARM) program, 1997
Beta-blocker use and outcomes among hospitalized
heart failure patients, 2462
B-type natriuretic peptide levels in obese patients
with advanced heart failure, 85
B-type natriuretic peptide strongly reflects diastolic
wall stress in patients with chronic heart
failure, 742
Cardiac function and heart failure, D18
Clinical presentation, management, and in-hospital
outcome of patients admitted with acute
decompensated heart failure with preserved
systolic function, 76
Comparison of the effects of carvedilol and
metoprolol on well-being, morbidity, and
mortality (the “patient journey”) in patients
with heart failure, 1603
Delayed gadolinium-enhanced cardiac magnetic
resonance in patients with chronic myocarditis
presenting with heart failure or recurrent
arrhythmias, 1649
Diabetes lowers six-minute walk test performance
in heart failure (correspondence), 1909
Diastolic heart failure can be diagnosed by
comprehensive two-dimensional and Doppler
echocardiography, 500
Early inflammation and risk of long-term
development of heart failure and mortality in
survivors of acute myocardial infarction, 962
Effects of gender on peak oxygen consumption and
the timing of cardiac transplantation, 2237
Emerging role of statins in the treatment of heart
failure (editorial), 342
Growing problem of obesity and the heart
(editorial), 617
Health status identifies heart failure outpatients at
risk for hospitalization or death, 752
Highlights of the year in JACC 2005, 184
Inspiratory muscle training in patients with heart
failure and inspiratory muscle weakness, 757
Intensive statin therapy and the risk of
hospitalization for heart failure after an acute
coronary syndrome in the PROVE IT-TIMI
22 study, 2326
Is brain natriuretic peptide production is decreased
in obese subjects? (correspondence), 886
Mapping the journey (editorial), 1612
Neutral effect on markers of heart failure,
inflammation, endothelial activation and
function, and vagal tone after high-dose
HMG-CoA reductase inhibition in non-
diabetic patients with non-ischemic
cardiomyopathy and average low-density
lipoprotein level, 338
Non-hypotensive low dose nesiritide has differential
renal effects compared to standard dose
nesiritide in patients with acute
decompensated heart failure and renal
dysfunction (correspondence), 2334
Prevalence of thiamin deficiency in hospitalized
patients with congestive heart failure, 354
Relationship between renal function and plasma
brain natriuretic peptide in patients with heart
failure, 582
Renal function, congestive heart failure, and amino-
terminal pro-brain natriuretic peptide
measurement, 91
Renal impairment and outcomes in heart failure:
systematic review and meta-analysis, 1987
Same bridge, new destinations, 930
Serum erythropoietin levels and infarct size (letter),
468
Transthyretin V122I in African Americans with
congestive heart failure (correspondence),
1724
Utility of impedance cardiography for the
identification of short-term risk of clinical
decompensation in stable patients with
chronic heart failure, 2245
Year in echocardiography, 856
Heart transplantation
Effects of gender on peak oxygen consumption and
the timing of cardiac transplantation, 2237
Timing for transplant; superior genetics or social
prejudice (editorial), 2243
Hematopoietic stem cells
Intracoronary delivery of hematopoietic bone
marrow stem cells and luminal loss of the
infarct-treated artery in patients with recent
myocardial infarction (correspondence), 1727
Heme oxygenase-1
Chronic recurrent myocardial ischemic injury is
significantly attenuated by pre-emptive adeno-
associated virus heme oxygenase-1 gene
delivery, 635
Hemodynamics
Diastolic stress echocardiography: hemodynamic
validation and clinical significance of
estimation of ventricular filling pressure with
exercise, 1891
Effects of combined versus selective adrenergic
blockade on left ventricular and systemic
hemodynamics, myocardial substrate
preference, and regional perfusion in
conscious dogs with dilated cardiomyopathy,
1871
Hemodynamic assessment of aortic stenosis
(editorial), 138
Hemodynamic phenomenon or geometric
discrepancy? (letter), 213
Paired ventricular stimulation: an approach for
hemodynamic stabilization during ventricular
tachycardia (correspondence), 2337
Rate, predictors, and consequences of hemodynamic
depression after carotid artery stenting, 1538
Hemorrhage
Comparison of the clinical impact of bleeding
measured by two different classifications
among patients with acute coronary
syndromes, 809
Risk of hemorrhage among patients with warfarin-
associated coagulopathy, 804
Hibernating myocardium
Hibernating myocardium (editorial), 978
Patients with hibernating myocardium show altered
left ventricular volumes and shape, which
revert after revascularization, 969
High density lipoprotein-cholesterol
Myeloperoxidase predicts progression of carotid
stenosis in states of low HDL-cholesterol,
2212
High-density lipoprotein cholesterol
Relationship between atheroma regression and
change in lumen size after infusion of
apolipoprotein A-I Milano, 992
Targeting cholesteryl ester transfer protein for the
prevention and management of cardiovascular
disease, 492
Highly active antiretroviral therapy
Cardiovascular risk in patients with human
immunodeficiency virus infection (editorial),
1124
HMG-CoA reductase inhibitors
See also Statins
Emerging role of statins in the treatment of heart
failure (editorial), 342
Neutral effect on markers of heart failure,
inflammation, endothelial activation and
function, and vagal tone after high-dose
HMG-CoA reductase inhibition in non-
diabetic patients with non-ischemic
cardiomyopathy and average low-density
lipoprotein level, 338
Homocysteine
Maternal homocysteine and congenital heart defects
(correspondence), 683
Hormone replacement therapy
Hormone replacement therapy and the
cardiovascular system, 1741
Hospitals
Clinical presentation, management, and in-hospital
outcome of patients admitted with acute
decompensated heart failure with preserved
systolic function, 76
Hospital improvement in time to reperfusion in
patients with acute myocardial infarction,
1999 to 2002, 45
Impact of hospital volume on racial disparities in
cardiovascular procedure mortality, 417
Risk score to predict in-hospital mortality for
percutaneous coronary interventions, 654
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Total of 1,007 percutaneous coronary interventions
without onsite cardiac surgery, 1713
Human immunodeficiency virus
Cardiovascular risk in patients with human
immunodeficiency virus infection (editorial),
1124
Functional and structural markers of atherosclerosis
in human immunodeficiency virus-infected
patients, 1117
Hypercholesterolemia
Oxidized low-density lipoprotein in children with
familial hypercholesterolemia and unaffected
siblings, 1803
Protective anti-inflammatory phenotype in high-risk
individuals who do not develop coronary
artery disease (correspondence), 1085
Hyperlipidemia
Safety and efficacy of long-term co-administration
of fenofibrate and ezetimibe in patients with
mixed hyperlipidemia, 1584
Hypersensitivity reactions
Allergic reactions after the implantation of drug-
eluting stents (editorial), 182
Hypersensitivity cases associated with drug-eluting
coronary stents, 175
Hypertension
See also Pulmonary arterial hypertension
Beta-blockade mitigates exercise blood pressure in
hypertensive male patients, 794
Development of mild aortic valve stenosis in a
rabbit model of hypertension, 2303
Hypertension, menopause, and coronary artery
disease risk in the Women’s Ischemia
Syndrome Evaluation (WISE) study, 50S
Hypertension and smoking are associated with
reduced regional left ventricular function in
asymptomatic individuals, 1150
Predictors of adverse outcome among patients with
hypertension and coronary artery disease, 547
Prognosis of masked hypertension and white-coat
hypertension detected by 24-h ambulatory
blood pressure monitoring (letter), 2127
Vascular disease, hypertension, and prevention, D3
Hypertrophic cardiomyopathy
See also Cardiomyopathy
AHA/ACCF scientific statement on the evaluation
of syncope, 473
Antifibrotic effects of antioxidant N-acetylcysteine
in a mouse model of human hypertrophic
cardiomyopathy mutation, 827
Fabry’s disease cardiomyopathy, 1663
Global and regional myocardial function
quantification by two-dimensional strain, 1175
Highlights of the year in JACC 2005, 184
Relevance of coronary microvascular flow
impairment to long-term remodeling and
systolic dysfunction in hypertrophic
cardiomyopathy, 1043
Hypothermia
Rapid induction of cerebral hypothermia is
enhanced with active compression-
decompression plus inspiratory impedance
threshold device cardiopulmonary resuscitation
in a porcine model of cardiac arrest, 835
Idiopathic dilated cardiomyopathy
Prognostic value of pacing-induced mechanical
alternans in patients with mild-to-moderate
idiopathic dilated cardiomyopathy in sinus
rhythm, 1382
Idiopathic pulmonary hypertension
Relationship of pulmonary arterial capacitance and
mortality in idiopathic pulmonary arterial
hypertension, 799
Imaging
See also Computed tomography; Magnetic
resonance imaging; Single-photon emission
computed tomography
Analysis of regional left ventricular function by
cineventriculography, cardiac magnetic
resonance imaging, and unenhanced and
contrast-enhanced echocardiography, 121
Epilogue: What do clinician expect from imagers?,
C101
Molecular and cellular imaging of atherosclerosis,
1328
President’s page: Making imaging beautiful, 1485
Task force 12: training in advanced cardiovascular
imaging (cardiovascular magnetic resonance
[CMR]), 910
Task force 12: training in advanced cardiovascular
imaging (computed tomography), 915
Treadmill exercise produces larger perfusion defects
than dipyridamole stress N-13 ammonia
positron emission tomography, 411
Immunosuppression
Coronary endothelial vasomotor function and
vascular remodeling in heart transplant
recipients randomized for tacrolimus or
cyclosporine immunosuppression, 1622
Impedance cardiography
Utility of impedance cardiography for the
identification of short-term risk of clinical
decompensation in stable patients with
chronic heart failure, 2245
Implantable cardioverter-defibrillators
Clinical research designs and implantable
defibrillator indications (editorial), 108
The cost effectiveness of implantable cardioverter-
defibrillators: results from the Multicenter
Automatic Defibrillator Implantation Trial
(MADIT)-II, 2310
Frequency and incremental cost of major
complications among Medicare beneficiaries
receiving implantable cardioverter
defibrillators, 2493
Implantable cardioverter-defibrillator therapy in
clinical practice, 1507
Limitations of left ventricular ejection fraction as
the major determinant for primary prevention
implantable cardioverter-defibrillators
(editorial), 1167
Microvolt T-wave alternans and the risk of death
or sustained ventricular arrhythmias in
patients with left ventricular dysfunction, 456
Predictive value of ventricular arrhythmia
inducibility for subsequent ventricular
tachycardia or ventricular fibrillation in
Multicenter Automatic Defibrillator
Implantation Trial (MADIT) II patients, 98
Reduction in ventricular tachyarrhythmias with
statins in the Multicenter Automatic
Defibrillator Implantation Trial (MADIT)-II,
769
Time dependence of defibrillator benefit after
coronary revascularization in the Multicenter
Automatic Defibrillator Implantation Trial
(MADIT)-II, 1811
Tincture of time (editorial), 1818
Year in clinical electrophysiology, 1207
Implantable loop recorders
Implantable loop recorder study of highly
symptomatic vasovagal patients, 587
Infarct
Intracoronary delivery of hematopoietic bone
marrow stem cells and luminal loss of the
infarct-treated artery in patients with recent
myocardial infarction (correspondence), 1727
Reproducibility of chronic and acute infarct size
measurement by delayed enhancement-
magnetic resonance imaging, 1641
Infarct-related arteries
Fractional flow reserve of infarct related arteries
identifies reversible defects on non-invasive
myocardial perfusion imaging early after
myocardial infarction, 2187
Infection
Oxidized LDL autoantibodies, chronic infections
and carotid atherosclerosis in a population-
based study, 2436
Infective endocarditis
Year in valvular heart disease, 427
Inflammation
Atorvastatin improves left ventricular systolic
function and serum markers of inflammation
in nonischemic heart failure, 332
Cellular immunostaining of angiotensin-converting
enzyme in human coronary atherosclerotic
plaques, 1143
Early inflammation and risk of long-term
development of heart failure and mortality in
survivors of acute myocardial infarction, 962
Link between arterial inflammation and circadian
rhythm: the oversight aspect in the year 2004
(letter), 688
Neutral effect on markers of heart failure,
inflammation, endothelial activation and
function, and vagal tone after high-dose
HMG-CoA reductase inhibition in non-
diabetic patients with non-ischemic
cardiomyopathy and average low-density
lipoprotein level, 338
Pregnancy associated plasma protein-A is markedly
expressed by monocyte-macrophage cells in
vulnerable and ruptured carotid atherosclerotic
plaques: a link between inflammation and
cerebrovascular events, 2201
Radionuclide imaging for the detection of
inflammation in vulnerable plaques, C57
Randomized trial to evaluate the relative protection
against post-PCI microvascular dysfunction,
ischemia and inflammation among anti-
platelet and anti-thrombotic agents: the
PROTECT–TIMI-30 trial, 2364
Relationship between increasing body weight,
insulin resistance, inflammation, adipocytokine
leptin, and coronary circulation function, 1188
Inheritance
Role of inheritance and environment in
predisposition to vascular disease in people of
African descent, 1126
Inspiratory impedance threshold device
Rapid induction of cerebral hypothermia is
enhanced with active compression-
decompression plus inspiratory impedance
threshold device cardiopulmonary resuscitation
in a porcine model of cardiac arrest, 835
Inspiratory muscle training
Inspiratory muscle training in patients with heart
failure and inspiratory muscle weakness, 757
In-stent restenosis
Randomized comparison of sirolimus-eluting stent
with balloon angioplasty in patients with in-
stent restenosis, 2152
Treatment of stent restenosis: moving beyond
momentum, 2161
Insulin
Glucose-insulin-potassium infusion in patients with
acute myocardial infarction without signs of
heart failure: The Glucose-Insulin-Potassium
Study (GIPS)-II (correspondence), 1730
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Insulin resistance
Relationship between increasing body weight,
insulin resistance, inflammation, adipocytokine
leptin, and coronary circulation function, 1188
Interleukin-6
Relationship between plasma osteoprotegerin levels
and coronary artery calcification in
uncomplicated type 2 diabetic subjects, 1850
Intermediate lesions
Drug-eluting stents in the treatment of
intermediate lesions: pooled analysis from four
randomized trials, 2164
Interstitial fibrosis
Antifibrotic effects of antioxidant N-acetylcysteine
in a mouse model of human hypertrophic
cardiomyopathy mutation, 827
Interventional cardiology
Aspirin and clopidogrel drug response in patients
undergoing percutaneous coronary
intervention, 27
Clinical characteristics predict benefits from
eptifibatide therapy during coronary stenting,
715
Clinical results of a platelet glycoprotein IIb/IIIa
receptor blocker (abciximab: ReoPro)-coated
stent in acute myocardial infarction, 933
Door-to-balloon time with primary percutaneous
coronary intervention for acute myocardial
infarction impacts late cardiac mortality in
high-risk patients and patients presenting
early after the onset of symptoms, 289
Geographical differences in the rates of
angiographic restenosis and ischemia-driven
target vessel revascularization after
percutaneous coronary interventions, 34
i2 innovation in intervention summit, D9
Sirolimus-eluting versus paclitaxel-eluting stent
implantation for the percutaneous treatment
of left main coronary artery disease, 507
Two-year outcomes after sirolimus-eluting stent
implantation, 1350
Year in interventional cardiology, 1689
Intima media thickness
Oxidized low-density lipoprotein in children with
familial hypercholesterolemia and unaffected
siblings, 1803
Role of inheritance and environment in
predisposition to vascular disease in people of
African descent, 1126
Intracoronary palpography
Intracoronary palpography for vulnerable plaque
assessment, C86
Intracoronary thermography
Intracoronary thermography for detection for high-
risk vulnerable plaques, C80
Intravascular radiation
Intravascular radiation detectors for the detection of
vulnerable atheroma, C97
Intravascular ultrasound
See also Ultrasound
Accuracy of 64-slice computed tomography to
classify and quantify plaque volumes in the
proximal coronary system, 672
Accuracy of in vivo coronary plaque morphology
assessment: a validation study of in vivo
virtual histology compared with in vitro
histopathology, (June 20: Nasu, Tsuchikane)
Assessment of vulnerable plaques causing acute
coronary syndrome using integrated
backscatter intravascular ultrasound, 734
Coronary arteries after arterial switch surgery
(letter), 1734
Highlights of the year in JACC 2005, 184
Imaging vulnerable plaque by ultrasound, C32
Intravascular ultrasound analysis of polymer-based
paclitaxel-eluting stents (letter), 470
Mechanisms and predictors of carotid artery stent
restenosis: a serial intravascular ultrasound
study, (June 20: Clark, Lessio)
Noninvasive detection of subclinical coronary
atherosclerosis coupled with assessment of
changes in plaque characteristics using novel
invasive imaging modalities, 1134
Quantification of coronary lesions by 64-slice
computed tomography compared with
quantitative coronary angiography and
intravascular ultrasound (letter), 891
Relationship between cardiovascular risk factors and
atherosclerotic disease burden measured by
intravascular ultrasound, 1967
Remodeling index compared to actual vascular
remodeling in atherosclerotic left main
coronary arteries as assessed with long-term
(12 months) serial intravascular ultrasound,
1363
Vascular effects of sirolimus-eluting versus bare
metal stents in diabetic patients: three-
dimensional ultrasound results of the
DIABETES trial, 2172
Iodine
Removal of iodine contrast from coronary sinus in
swine during coronary angiography
(correspondence), 465
Ischemia
Endovascular therapy for chronic mesenteric
ischemia, 944
Geographical differences in the rates of
angiographic restenosis and ischemia-driven
target vessel revascularization after
percutaneous coronary interventions, 34
Mental stress provokes ischemia in coronary artery
disease subjects without exercise- or
adenosine-induced ischemia, 987
Randomized trial to evaluate the relative protection
against post-PCI microvascular dysfunction,
ischemia and inflammation among anti-
platelet and anti-thrombotic agents: the
PROTECT–TIMI-30 trial, 2364
Ischemic cardiomyopathy
Prognostic utility of microvolt T-wave alternans in
risk stratification of patients with ischemic
cardiomyopathy, 1820
Ischemic heart disease
Comparison of B-type natriuretic peptides for
assessment of cardiac function and prognosis
in stable ischemic heart disease, 52
Insights from the NHLBI-sponsored Women’s
Ischemia Syndrome Evaluation (WISE) study,
4S
Ischemic heart disease in women, 1S
Some thoughts on the vasculopathy of women with
ischemic heart disease, 30S
Tibolone improves myocardial perfusion in
postmenopausal women with ischemic heart
disease, 559
Women, ischemic heart disease, revascularization,
and the gender gap, 63S
Women and ischemic heart disease, 66S
Ischemic mitral regurgitation
Autologous myoblast transplantation for chronic
ischemic mitral regurgitation, 2086
Ischemic preconditioning
Randomised controlled trial of the effects of remote
ischemic preconditioning on children
undergoing cardiac surgery; first clinical
application in humans, 2277
JACC
Highlights of the year in JACC 2005, 184
Kidneys
Assessment of renal flow and flow reserve in
humans, 620
Cardiovascular morbidity and mortality in the
Atherosclerosis and Folic Acid
Supplementation Trial (ASFAST) in chronic
renal failure, 1108
Non-hypotensive low dose nesiritide has differential
renal effects compared to standard dose
nesiritide in patients with acute
decompensated heart failure and renal
dysfunction (correspondence), 2334
Relationship between renal function and plasma
brain natriuretic peptide in patients with heart
failure, 582
Renal function, congestive heart failure, and amino-
terminal pro-brain natriuretic peptide
measurement, 91
Renal impairment and outcomes in heart failure:
systematic review and meta-analysis, 1987
Role of diminished renal function in cardiovascular
mortality, 1
Left atrial ablation
Left atrial ablation versus biatrial ablation for
persistent and permanent atrial fibrillation,
2504
Left atrial appendage
Does percutaneous closure of the left atrial
appendage prevent stroke in atrial fibrillation?
(letter), 1500
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